Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel Study of Oral 6R-BH4 in Subjects With Isolated Systolic Hypertension and Endothelial Dysfunction
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Sapropterin (Primary)
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- 17 Aug 2017 Status changed from recruiting to discontinued.